Search form

New York State Enacted Budget Includes Opioid Legislation

By Lisa M. Marrello and Thomas Buchan
  • April 25, 2018

As part of the 2018-2019 New York State Budget, the Governor and the Legislature have agreed to a package of legislation addressing the opioid crisis in New York that includes requiring opioid manufacturers and distributors to help fund treatment programs.

Prescription Limits

The final Budget contains legislation that will limit the prescription of opioids to a patient for the treatment of pain to three months or the period of time it normally takes for tissue to heal, unless the patient’s medical records contain a treatment plan. (§7 of Part D, S.7507-C/ A.9507-C.) All treatment plans must meet generally accepted national, professional, or government guidelines.

Patients who are being treated for cancer and are not in remission, patients in hospice or other end-of-life care, and patients being treated as part of a palliative care practice are exempt from this provision.

Fentanyl Analogs, Synthetic Cannabinoids Added to Controlled Substance Schedules

The Budget contains provisions that would add Fentanyl analogs, synthetic cannabinoids, and cannabimimetic agents to the list of Schedule I controlled substances under New York’s Public Health Law. (Part BB, S.7507-C/ A.9507-C.)

The schedules of controlled substances are used to combat the illegal use and trade of substances, or their analogs or derivatives, and to govern the use of those substances in health care.

Opioid Stewardship Payment

The Budget contains a provision called the “Opioid Stewardship Act.” (Part NN, S.7507-C/ A.9507-C.) The Opioid Stewardship Act requires all manufacturers and distributors of opioids to provide an annual payment to a new “Opioid Stewardship Fund” that will total $100 million in all payments from all manufacturers and distributors.

The Fund will be used to support programs operated by the New York State Office of Alcoholism and Substance Abuse Services (OASAS) to provide opioid treatment, recovery, prevention, educational programs, and support for the state’s prescription monitoring program registry.

Each manufacturer and distributor will be required to pay a ratable share of the total payment, which will be based on the proportion of milligrams of morphine equivalents (MMEs) sold by each manufacturer or distributor in New York.

Independent Substance Use Disorder and Mental Health Ombudsman

Finally, the Budget creates an independent substance use disorder and mental health ombudsman within OASAS. (Part FF, S.7507-C/ A.9507-C.) The ombudsman will assist individuals with a substance use disorder or mental illness to ensure they receive appropriate health insurance coverage.

The Jackson Lewis Government Relations practice monitors and tracks all legislation introduced in New York, advocates for client positions with New York’s legislators, and helps clients oppose legislation that will be detrimental to their business interests. We have are been involved in all phases of the New York State Budget process, from the Governor’s Executive Budget Proposal, through the Final Enacted State Fiscal Year Budget. For details of other provisions in the Budget, see our articles, New York Legislature Passes Significant Changes to Laws Combating Sexual Harassment in the Workplace and New York State Budget Includes Optional Employer Payroll Tax as a Potential SALT Cap Work Around.

Please contact any member of the Government Relations practice or the Jackson Lewis attorney with whom you regularly work for assistance.

©2018 Jackson Lewis P.C. This material is provided for informational purposes only. It is not intended to constitute legal advice nor does it create a client-lawyer relationship between Jackson Lewis and any recipient. Recipients should consult with counsel before taking any actions based on the information contained within this material. This material may be considered attorney advertising in some jurisdictions. Prior results do not guarantee a similar outcome.

Reproduction of this material in whole or in part is prohibited without the express prior written consent of Jackson Lewis P.C., a law firm with more than 900 attorneys in major cities nationwide serving clients across a wide range of practices and industries. Having built its reputation on providing premier workplace law representation to management, the firm has grown to include leading practices in the areas of government relations, healthcare and sports law. For more information, visit www.jacksonlewis.com.

See AllRelated Articles You May Like

April 12, 2019

New York City Employers May Be Barred from Testing Job Applicants for Marijuana Use

April 12, 2019

The New York City Council has passed a prohibition on New York City employers requiring prospective employees to submit to testing for the presence of any tetrahydrocannabinols (THC), the active ingredient in marijuana. If Intro 1445-A becomes law, it will be the first of its kind in the United States. Mayor Bill de Blasio is expected... Read More

April 10, 2019

Highlights from the New York FY 2020 Budget

April 10, 2019

New York legislators passed into law the fiscal year 2020 $175.5-billion budget on April 1, 2019, fully funding state government for the next fiscal year. Among the provisions enacted are many that affect labor and employment in general and the energy, media, finance, health care, and other industries in particular. This is the first... Read More

February 28, 2019

New York Labor Department No Longer Pursuing Call-In Pay Regulations

February 28, 2019

The New York State Department of Labor (NYSDOL) is no longer pursuing regulations on “call-in pay,” or predictive scheduling, that would affect most New York employers. The regulations would have required employers, among other things, to provide call-in pay (ranging from two to four hours at the minimum wage) if: Employers do... Read More